One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 617-621

  Yousfi, M M ^a   El Zimaity, H M T ^a   Genta, R M ^a   Graham, D Y ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; FEMALE; HEADACHE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; TASTE DISORDER;

EID: 0030016498     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.23164000.x     Document Type: Article

References (42)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-27.
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. J Am Med Ass 1994; 272: 65-9.
3. Peura DA, Graham DY. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. Am J Gastroenterol 1994; 89: 1137-9.
4. Bank S, Chow K, Greenburg R. Helicobacter pylori and recurrence of duodenal ulcers. Am J Gastroenterol 1992; 87: 1365-7.
5. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1995; 6: 76-89.
6. Graham DY. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma. Prev Med 1994; 23: 712-6.
7. Fennerty MR. Helicobacter pylori. Arch Intern Med 1994; 154: 721-7.
8. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. New Engl J Med 1995; 555: 984-91.
9. Rune SJ. Treatment stratigies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients. Scand J Gastroenterol 1494; 24 (Suppl. 205): 45-7.
10. Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545-51.
11. Börsch GM, Graham DY. Helicobacter pylori. In: Collen MJ, Benjamin SB, eds. Pharmacology of Peptic Ulcer Disease. Handbook of Experimental Pharmacology, Vol. 99. Berlin: Springer, 1991: 107-48.
12. Borody TJ, Cole P, Noonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431-5.
13. Glupczynski Y, Burette A, De Koster E, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7. (Letter.)
14. O'Riordan TG, Mathai E, Tobin E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990; 31: 999-1002.
15. Weil J, Bell GD, Powell K, et al. Helicobacter pylori and metronidazole resistance. Lancet 1990; 336: 1445. (Letter.)
16. Becx MC, Janssen AJ, Clasener HA, de Koning RW. Metronidazole-resistant Helicobacter pylori. Lancet 1990; 335: 539-40. (Letter.)
17. Weil J, Bell GD, Powell K, et al. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther 1990; 4: 651-7.
18. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
19. Ozmen MM, Johnson CD. Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? Am J Gastroenterol 1995; 90: 1542-3. (Letter.)
20. Moayyedi P, Sahay P, Tompkins DS, Axon AT. Efficacy and optimal dose of omeprazole in a new 7-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1996; 7: 835-40.
21. Labenz J, Peitz U, Tillenburg B, et al. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori. Leber Magen Darm 1995; 25: 125-7.
22. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5.
23. Adamek RJ, Opferkuch W, Wegener M. Modified short-term triple therapy - ranitidine, clarithromycin, and metronidazole - for cure of Helicobacter pylori infection. Am J Gastroenterol 1995; 1: 168-9.
24. Yousfi MM, El-Zimaity HMT, Al-Assi MT, et al. Metronidazole, omeprazole, and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 209-12.
25. Yousfi MM, El-Zimaity HMT, Al-Assi MT, et al. Metronidazole, ranitidine, and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther 1996; 10: 119-22.
26. de Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20.
27. de Boer WA, Driessen WM, Potters VP, Tytgat GN. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89: 1993-7.
28. Malanoski GJ, Eliopoulos GM, Ferraro MJ, et al. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis 1993; 12: 131-3.
29. Nagate T, Numata K, Hanada K, Kondo I. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics. J Clin Gastroenterol 1990; 12 (Suppl. 1): S135-8.
30. Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994; 25: 221-6.
31. Graham DY, Karttunen TJ, Genta RM. The evaluation of treatment of H. pylori infections: strategies for the design of clinical trials. Endosc Dig 1994; 6: 991-1006.
32. Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylori: comparison of E test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diag Microbiol Infect Dis 1996; 24: 37-41.
33. Graham DY, Klein PD, Opekun AR, et al. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol 1989; 84: 233-8.
34. Penston JG. Review article: Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
35. Xia HX, Daw MA, Beattie S, Keane CT, O'Morain CA. Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients. Ir J Med Sci 1995; 162: 91-4.
36. Lind T, Veldhuyzen Van Zanten SJO, Unge P, et al. The MACH 1 study: optimal one-week treatment for Helicobacter pylori defined? Gut 1995; 37 (Suppl. 1): A4.
37. Cayla R, Zerbib F, De Mascare A, Megraud F, Lamouiliatte H. Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for Helicobacter pylori eradication: results of a randomized controlled trial among 100 patients. Am J Gastroenterol 1995; 89: A1366.
38. Neves B, Shee Va, Duarte C, Quina M. Amoxicillin/omeprazole versus amoxicillin/omeprazole/clarithromycin for eradication of Helicobacter pylori. Gastroenterology 1995; 108: A177.
39. Lamouliatte H, Cayla R, Zerbib F, Megraud F. Triple therapy with proton pump inhibitor - amoxicillin and clarithromycin for Helicobacter pylori eradication. Gastroenterology 1995; 108: A143.
40. Hirschowitz BI, Mohen J, Shaw S. Omeprazole with amoxicillin alone or with clarithromycin to treat Helicobacter pylori. Gastroenterology 1995; 108: A115.
41. Delchier IC, Elamine I, Goldfain D, et al. Comparison of omeprazole + amoxicillin versus omeprazole + amoxicillin + clarithromycin in the eradication of Helicobacter pylori - results from a randomized study involving 120 patients. Gastroenterology 1995; 108: A81.
42. Al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Clarithromycin-amoxycillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1994; 8: 453-6.